A Population Based Epidemiological Study on Myasthenia Gravis in Estonia

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2003 Nov 26

PMID 14638881

Citations 9

Authors

M Oopik

A-E Kaasik

J Jakobsen

Affiliations

Soon will be listed here.

Abstract

Objective: To describe the occurrence of myasthenia gravis in the Baltic area.

Methods: Data were obtained from hospital files recorded during the period 1942 to 1996 from neurologists and the patient organisation. Survival data were checked with the Estonian Citizenship and Migration Board. Prevalence was determined on 1 January 1997. A questionnaire on the course of myasthenia gravis was sent to all the prevalent patients.

Results: The size of the population surveyed was 1 462 130. The average annual incidence from 1970 to 1996 was 4.0 per million (women, 5.2; men, 2.6). The point prevalence was 99 per million (women, 133; men 59). The incidence in the younger age group (<50 years) was 3.4 per million (women, 4.8; men, 1.9) and in the older age group (>or=50 years), 5.5 (women, 5.9; men, 4.9). The prevalence ratio was twofold higher in the older age group (p<0.0001)-for men (p = 0.034) as well as for women (p<0.001).

Conclusions: Prevalence and incidence values of myasthenia gravis from Estonia are similar to those reported in most studies from Europe and north America. However, there seems to be a higher frequency in the elderly (>or=50 years) in Estonia.

Citing Articles

Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P J Transl Med. 2021; 19(1):516.

PMID: 34930325 PMC: 8686543. DOI: 10.1186/s12967-021-03185-7.

Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries.

Sabre L, Westerberg E, Liik M, Punga A Brain Behav. 2017; 7(4):e00653.

PMID: 28413704 PMC: 5390836. DOI: 10.1002/brb3.653.

The Epidemiology of Myasthenia Gravis in Korea.

Lee H, Lee H, Shin H, Choi Y, Kim S Yonsei Med J. 2016; 57(2):419-25.

PMID: 26847295 PMC: 4740535. DOI: 10.3349/ymj.2016.57.2.419.

Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.

Foldvari A, Kovacs N, Sipos V, Merth G, Vincze F, Szucs M Wien Klin Wochenschr. 2015; 127(11-12):459-64.

PMID: 25990531 DOI: 10.1007/s00508-015-0796-5.

Prevalence of factors associated with poor outcomes of hospitalized myasthenia gravis patients in Thailand.

Tiamkao S, Pranboon S, Thepsuthammarat K, Sawanyawisuth K Neurosciences (Riyadh). 2014; 19(4):286-90.

PMID: 25274587 PMC: 4727666.

References

Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, Stevic Z, Lavrnic S, Pavlovic S . Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand. 1999; 100(3):168-74. DOI: 10.1111/j.1600-0404.1999.tb00733.x. View

Zivadinov R, Jurjevic A, Willheim K, Cazzato G, Zorzon M . Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. Neuroepidemiology. 1998; 17(5):265-72. DOI: 10.1159/000026179. View

Phillips 2nd L, Torner J . Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology. 1996; 47(5):1233-8. DOI: 10.1212/wnl.47.5.1233. View

Beekman R, Kuks J, OOSTERHUIS H . Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol. 1997; 244(2):112-8. DOI: 10.1007/s004150050059. View

Gudmundsson K . The prevalence of some neurological diseases in Iceland. Acta Neurol Scand. 1968; 44(1):57-69. DOI: 10.1111/j.1600-0404.1968.tb07443.x. View

Christensen P, Jensen T, Tsiropoulos I, Sorensen T, Kjaer M, Rasmussen M . Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology. 1993; 43(9):1779-83. DOI: 10.1212/wnl.43.9.1779. View

Pirskanen R . Genetic aspects in myasthenia gravis. A family study of 264 Finnish patients. Acta Neurol Scand. 1977; 56(5):365-88. View

Somnier F, Keiding N, Paulson O . Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991; 48(7):733-9. DOI: 10.1001/archneur.1991.00530190081019. View

STORM-MATHISEN A . Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand. 1984; 70(4):274-84. DOI: 10.1111/j.1600-0404.1984.tb00825.x. View

10.

Phillips 2nd L, Torner J, Anderson M, Cox G . The epidemiology of myasthenia gravis in central and western Virginia. Neurology. 1992; 42(10):1888-93. DOI: 10.1212/wnl.42.10.1888. View

11.

Malone J, Fedok F, Belchis D, Maloney M . Basal cell carcinoma metastatic to the parotid: report of a new case and review of the literature. Ear Nose Throat J. 2000; 79(7):511-5, 518-9. View

12.

Krivopusk M . [Clinico-epidemiological aspects of hereditary neuromuscular diseases in the Krasnodar territory]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1991; 91(9):3-5. View

13.

Sorensen T, Holm E . Myasthenia gravis in the county of Viborg, Denmark. Eur Neurol. 1989; 29(3):177-9. DOI: 10.1159/000116405. View

14.

Schon F, Drayson M, Thompson R . Myasthenia gravis and elderly people. Age Ageing. 1996; 25(1):56-8. DOI: 10.1093/ageing/25.1.56. View

15.

OOSTERHUIS H . The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989; 52(10):1121-7. PMC: 1031695. DOI: 10.1136/jnnp.52.10.1121. View

16.

Kurtzke J . Epidemiology of myasthenia gravis. Adv Neurol. 1978; 19:545-66. View

17.

DONALDSON D, Ansher M, Horan S, Rutherford R, Ringel S . The relationship of age to outcome in myasthenia gravis. Neurology. 1990; 40(5):786-90. DOI: 10.1212/wnl.40.5.786. View

18.

DAlessandro R, Granieri E, Benassi G, Tola M, Casmiro M, Mazzanti B . Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurol Scand. 1991; 83(2):83-8. DOI: 10.1111/j.1600-0404.1991.tb04654.x. View

19.

Hokkanen E . Epidemiology of myasthenia gravis in Finland. J Neurol Sci. 1969; 9(3):463-78. DOI: 10.1016/0022-510x(69)90090-2. View

20.

Aarli J . Late-onset myasthenia gravis: a changing scene. Arch Neurol. 1999; 56(1):25-7. DOI: 10.1001/archneur.56.1.25. View